| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.3 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.15 | 0.3 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |